Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

Edgewell Personal Care share price today

Edgewell Personal Care Company · EPC · Consumer Staples · Household & Personal Products · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists

Edgewell Personal Care share price: $29.66 at the close on 4 November 2026, +58.4% in a year.

$29.66Price +58.4% in a year
$570 MRevenue (Jun 2026)
$13.7 MProfit (Jun 2026)
8.8%Operating margin
2%ROE FY25
7.3%ROIC against a 5.2% cost of capital: +2.1 points

Edgewell Personal Care Company's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer.

The main question: the share price moved +58.4% in a year while yearly earnings per share moved −73.1%. The difference came from the market paying a higher multiple.

The price has been between phases. Over the last four quarters, results have been mixed, and 237% of the last 3 years' profit came in as cash. What will decide it: whether earnings grow into a price that has already moved.

What is the Edgewell Personal Care share price today?

Edgewell Personal Care Company's share price was $29.66 at the close on 4 November 2026. That is 23.3% above its average price over the last 200 trading days. In the last 52 weeks it traded between $16 and $30, and at that close it was at the high of that range.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). The phase helps read everything below.

Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 2 weeks in a row.

Nov 2026: $29.66, 23.3% above its 200-day average.

  • Price $29.66
  • 50-day avg $27.80
  • 200-day avg $24.06
Nov 2026: $29.66, 23.3% above its 200-day average.
WeekPrice50-day avg200-day avg
11 Jul 2025$27.10––
18 Jul 2025$25.56––
25 Jul 2025$27.00––
1 Aug 2025$25.16––
8 Aug 2025$22.03––
15 Aug 2025$22.93––
22 Aug 2025$23.96––
29 Aug 2025$24.02––
5 Sep 2025$23.40––
12 Sep 2025$21.71––
19 Sep 2025$20.32$23.75–
26 Sep 2025$19.74$23.10–
3 Oct 2025$20.44$22.51–
10 Oct 2025$19.65$21.92–
17 Oct 2025$20.26$21.64–
24 Oct 2025$19.69$21.36–
31 Oct 2025$19.39$20.97–
7 Nov 2025$18.73$20.52–
14 Nov 2025$18.13$20.00–
21 Nov 2025$17.53$19.53–
28 Nov 2025$17.86$19.26–
5 Dec 2025$16.73$18.99–
12 Dec 2025$17.40$18.65–
19 Dec 2025$17.52$18.41–
26 Dec 2025$17.48$18.20–
2 Jan 2026$16.86$17.97–
9 Jan 2026$18.20$17.72–
16 Jan 2026$18.67$17.67–
23 Jan 2026$19.56$17.70–
30 Jan 2026$19.46$17.78–
6 Feb 2026$20.75$18.07–
13 Feb 2026$21.89$18.41–
20 Feb 2026$22.72$18.85–
27 Feb 2026$22.74$19.38–
6 Mar 2026$21.13$19.76–
13 Mar 2026$19.76$20.03–
20 Mar 2026$19.43$20.33–
27 Mar 2026$21.02$20.53–
2 Apr 2026$20.98$20.71–
10 Apr 2026$21.89$20.94–
17 Apr 2026$23.40$21.23–
24 Apr 2026$23.41$21.52$20.72
1 May 2026$22.56$21.58$20.63
8 May 2026$21.25$21.51$20.52
15 May 2026$15.93$21.13$20.31
22 May 2026$17.66$20.79$20.15
29 May 2026$17.52$20.59$20.05
5 Jun 2026$19.87$20.51$19.95
12 Jun 2026$22.94$20.53$19.89
18 Jun 2026$23.11$20.67$19.88
26 Jun 2026$27.72$21.02$19.94
2 Jul 2026$27.21$21.36$20.06
10 Jul 2026$26.48$21.67$20.20
17 Jul 2026$29.66$22.28$20.41
24 Jul 2026$27.63$22.96$20.59
31 Jul 2026$27.19$24.07$20.79
7 Aug 2026$28.38$25.16$20.99
14 Aug 2026$28.42$26.21$21.21
21 Aug 2026$28.57$26.99$21.43
28 Aug 2026$29.05$27.61$21.68
4 Sep 2026$28.87$27.97$21.93
11 Sep 2026$26.93$27.95$22.13
18 Sep 2026$27.18$27.99$22.36
25 Sep 2026$27.82$27.97$22.63
2 Oct 2026$26.97$27.89$22.88
9 Oct 2026$27.80$27.84$23.12
16 Oct 2026$27.91$27.85$23.39
23 Oct 2026$28.06$27.81$23.67
30 Oct 2026$28.57$27.80$23.92
4 Nov 2026$29.66$27.80$24.06
Weekly closing price ($) with its 50-day and 200-day averages. 1-year window.

Week by week since 2025: did it beat the S&P 500 over the past 13 weeks?

Ahead in 31 of 57 weeks

Week by week since 2025: did it beat the S&P 500 over the past 13 weeks?
Week13-week return vs S&P 500
11 Jul 2025no S&P 500 reading
18 Jul 2025no S&P 500 reading
25 Jul 2025no S&P 500 reading
1 Aug 2025no S&P 500 reading
8 Aug 2025no S&P 500 reading
15 Aug 2025no S&P 500 reading
22 Aug 2025no S&P 500 reading
29 Aug 2025no S&P 500 reading
5 Sep 2025no S&P 500 reading
12 Sep 2025no S&P 500 reading
19 Sep 2025no S&P 500 reading
26 Sep 2025no S&P 500 reading
3 Oct 2025no S&P 500 reading
10 Oct 2025−32.2%
17 Oct 2025−26.6%
24 Oct 2025−33.4%
31 Oct 2025−32.6%
7 Nov 2025−20.3%
14 Nov 2025−25.4%
21 Nov 2025−29.0%
28 Nov 2025−31.6%
5 Dec 2025−34.4%
12 Dec 2025−23.6%
19 Dec 2025−16.3%
26 Dec 2025−15.8%
2 Jan 2026−19.6%
9 Jan 2026−13.7%
16 Jan 2026−12.0%
23 Jan 2026−2.4%
30 Jan 2026−1.1%
6 Feb 2026+7.9%
13 Feb 2026+19.3%
20 Feb 2026+25.0%
27 Feb 2026+26.9%
6 Mar 2026+28.2%
13 Mar 2026+16.4%
20 Mar 2026+15.6%
27 Mar 2026+28.4%
2 Apr 2026+28.4%
10 Apr 2026+22.4%
17 Apr 2026+22.7%
24 Apr 2026+16.1%
1 May 2026+11.8%
8 May 2026−4.4%
15 May 2026−35.6%
22 May 2026−30.4%
29 May 2026−33.2%
5 Jun 2026−15.7%
12 Jun 2026+4.1%
18 Jun 2026+3.8%
26 Jun 2026+16.9%
2 Jul 2026+16.1%
10 Jul 2026+9.9%
17 Jul 2026+22.1%
24 Jul 2026+14.5%
31 Jul 2026+16.9%
7 Aug 2026+28.7%
14 Aug 2026+73.4%
21 Aug 2026+59.1%
28 Aug 2026+64.1%
4 Sep 2026+40.9%
11 Sep 2026+14.4%
18 Sep 2026+15.6%
25 Sep 2026−5.5%
2 Oct 2026−4.2%
9 Oct 2026+1.9%
16 Oct 2026−8.6%
23 Oct 2026−1.3%
30 Oct 2026+3.9%
4 Nov 2026+5.3%
Each bar is one week, from 2025 to now (57 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the S&P 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 1 year the share price moved +9% while the S&P 500 moved +23%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What dividend does Edgewell Personal Care pay?

Edgewell Personal Care Company paid $0.60 per share over the last four reported quarters. The most recent declaration was $0.15 for Jun 2026. At today's price of $29.66 that is a yield of 2.02%, based on dividends already paid, not a forecast.

A dividend is cash paid out for each share. The 12-month total is the four most recent quarters added together.

Dividend per share each quarter: latest $0.15 (Jun 2026)

  • Dividend per share $0.15
Dividend per share each quarter: latest $0.15 (Jun 2026)
QuarterDividend per share
Sep 2023$0.15
Dec 2023$0.15
Mar 2024$0.15
Jun 2024$0.15
Sep 2024$0.15
Dec 2024$0.15
Mar 2025$0.15
Jun 2025$0.15
Sep 2025$0.15
Dec 2025$0.15
Mar 2026$0.15
Jun 2026$0.15
Declared dividend per share, $ a share, each reported quarter. 12 quarters on file.

Which stock lists is Edgewell Personal Care on?

Edgewell Personal Care is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

Is Edgewell Personal Care profitable?

Edgewell Personal Care Company earned $13.7 M of net profit in the Jun 2026 quarter. Full-year FY25 profit was $25.4 M. Over 4 years profit has grown −31.9% a year on average. That is 2.4% of the quarter's revenue. The same quarter a year earlier earned $49.0 M. 2 of the last 8 reported quarters were loss-making.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY25 profit was $25.4 M (−74.2% on the year before).

FY25 profit $25.4 M (−74.2% on the year before), −31.9% a year over 4 years

  • Net profit $25.4 M
FY25 profit $25.4 M (−74.2% on the year before), −31.9% a year over 4 years
QuarterNet profit
FY21$118 M
FY22$99.5 M
FY23$115 M
FY24$98.6 M
FY25$25.4 M

Growth on a year earlier

  • Growth on a year earlier −74.2%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY22−15.5%
FY2315.3%
FY24−14%
FY25−74.2%
Top: net profit each year, $ M. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $13.7 M

  • Net profit (quarterly) $13.7 M
Jun 2026: $13.7 M
QuarterNet profit (quarterly)
Sep 2023$29.9 M
Dec 2023$4.8 M
Mar 2024$36.0 M
Jun 2024$49.0 M
Sep 2024$8.8 M
Dec 2024–
Mar 2025–
Jun 2025–
Sep 2025–
Dec 2025−$65.7 M
Mar 2026−$10.6 M
Jun 2026$13.7 M

Growth on a year earlier

  • Growth on a year earlier −70.6%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 2023−13.6%
Dec 2023−61.3%
Mar 202485.6%
Jun 2024−7.5%
Sep 2024−70.6%
Dec 2024–
Mar 2025–
Jun 2025–
Sep 2025–
Dec 2025–
Mar 2026–
Jun 2026–
Top: net profit each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

How much revenue does Edgewell Personal Care make, and is it growing?

Edgewell Personal Care Company reported $570 M of revenue in the Jun 2026 quarter. Over 4 years it has grown 1.6% a year on average. The last full year, FY25, came in at $2.2 B.

Revenue is everything the company billed its customers in the period.

The quarterly figures for FY25 do not add up to the full-year total on file, so those quarters are left out of the charts and sums.

FY25 revenue was $2.2 B, −1.3% on the year before.

FY25 revenue $2.2 B (−1.3% on the year before), 1.6% a year over 4 years

  • Revenue $2.2 B
FY25 revenue $2.2 B (−1.3% on the year before), 1.6% a year over 4 years
QuarterRevenue
FY21$2.1 B
FY22$2.2 B
FY23$2.3 B
FY24$2.3 B
FY25$2.2 B

Growth on a year earlier

  • Growth on a year earlier −1.3%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY224%
FY233.7%
FY240.1%
FY25−1.3%
Top: revenue each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $570 M

  • Revenue (quarterly) $570 M
Jun 2026: $570 M
QuarterRevenue (quarterly)
Sep 2023$534 M
Dec 2023$489 M
Mar 2024$599 M
Jun 2024$648 M
Sep 2024$518 M
Dec 2024–
Mar 2025–
Jun 2025–
Sep 2025–
Dec 2025$423 M
Mar 2026$520 M
Jun 2026$570 M

Growth on a year earlier

  • Growth on a year earlier −3.1%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 2023−0.5%
Dec 20234.2%
Mar 20240.2%
Jun 2024−0.3%
Sep 2024−3.1%
Dec 2024–
Mar 2025–
Jun 2025–
Sep 2025–
Dec 2025–
Mar 2026–
Jun 2026–
Top: revenue each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

How much of every $100 of sales does Edgewell Personal Care keep?

Edgewell Personal Care Company's operating margin was 8.8% in the Jun 2026 quarter. Across 5 years it has been between 9.3% and 13.5%. The latest quarter is below every full year in that period.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −5.2 percentage points on the year while gross margin changed −0.2 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

FY25: 9.3%, within a range of 9.3% to 13.5% over 5 years

  • Operating margin 9.3%
FY25: 9.3%, within a range of 9.3% to 13.5% over 5 years
QuarterOperating margin
FY2113.5%
FY2210.7%
FY2310.7%
FY2411.3%
FY259.3%

Change on the year before (points)

  • Change on the year before (points) −2.0 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY21–
FY22−2.8 pts
FY230.0 pts
FY24+0.6 pts
FY25−2.0 pts
Operating margin each year, % (top). Below: change on the year before, in percentage points. 5-year window.

Jun 2026: operating margin 8.8%

  • Operating margin 8.8%
Jun 2026: operating margin 8.8%
QuarterOperating margin
Sep 202311%
Dec 20237.1%
Mar 202413.1%
Jun 202414%
Sep 20249.8%
Dec 2024–
Mar 2025–
Jun 2025–
Sep 2025–
Dec 20251.9%
Mar 20269%
Jun 20268.8%

Change on a year earlier (points)

  • Change on a year earlier (points) −1.2 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Sep 2023−2.7 pts
Dec 2023−0.8 pts
Mar 2024+2.7 pts
Jun 2024+1.2 pts
Sep 2024−1.2 pts
Dec 2024–
Mar 2025–
Jun 2025–
Sep 2025–
Dec 2025–
Mar 2026–
Jun 2026–
Top: quarterly operating margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Operating profit as a share of revenue, each quarter.

Is Edgewell Personal Care's profit turning into cash?

Over the last 3 years, 237% of Edgewell Personal Care Company's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $118 M of operating cash against $25.4 M of profit. After $77.0 M of spending on assets, $41.4 M was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

FY25: operating cash $118 M against profit $25.4 M; 237% of 3 years' profit came in as cash

  • Operating cash $118 M
  • Net profit $25.4 M
  • Free cash $41.4 M
FY25: operating cash $118 M against profit $25.4 M; 237% of 3 years' profit came in as cash
QuarterOperating cashNet profitFree cash
FY21$229 M$118 M$172 M
FY22$102 M$99.5 M$45.6 M
FY23$216 M$115 M$167 M
FY24$231 M$98.6 M$175 M
FY25$118 M$25.4 M$41.4 M
Operating cash flow and net profit each year, $ M. The line is free cash flow: operating cash minus spending on assets. 5-year window, yearly figures.

Jun 2026: operating cash $119 M = 866% of the quarter's profit

  • Operating cash (quarterly) $119 M
Jun 2026: operating cash $119 M = 866% of the quarter's profit
QuarterOperating cash (quarterly)
Sep 2023$47.8 M
Dec 2023−$72.9 M
Mar 2024$129 M
Jun 2024$101 M
Sep 2024$73.7 M
Dec 2024−$116 M
Mar 2025$45.1 M
Jun 2025$115 M
Sep 2025$74.1 M
Dec 2025−$126 M
Mar 2026$54.3 M
Jun 2026$119 M

Operating cash as % of profit

  • Operating cash as % of profit 866%
Operating cash as % of profit
QuarterOperating cash as % of profit
Sep 2023160%
Dec 2023−1,519%
Mar 2024358%
Jun 2024207%
Sep 2024838%
Dec 2024–
Mar 2025–
Jun 2025–
Sep 2025–
Dec 2025–
Mar 2026–
Jun 2026866%
Top: operating cash each quarter, $ M. Below: operating cash as a % of net profit; 100% means all of the quarter's profit came in as cash. Last 12 quarters.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

Where does Edgewell Personal Care's cash go?

Edgewell Personal Care Company does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $183 M on assets over the last 3 years. Averaged over those years that is 2.7% of FY25 revenue a year.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Spending on assets: $183 M over the last 3 years.

FY25: capex $77.0 M, steady spending

  • Capex $77.0 M
FY25: capex $77.0 M, steady spending
QuarterCapex
FY21$56.8 M
FY22$56.4 M
FY23$49.5 M
FY24$56.5 M
FY25$77.0 M
Capital spending each year, $ M.

Jun 2026: capex $15.6 M in the quarter

  • Capex (quarterly) $15.6 M
Jun 2026: capex $15.6 M in the quarter
QuarterCapex (quarterly)
Sep 2023$18.4 M
Dec 2023$6.5 M
Mar 2024$11.5 M
Jun 2024$12.6 M
Sep 2024$25.9 M
Dec 2024$16.8 M
Mar 2025$17.1 M
Jun 2025$15.5 M
Sep 2025$27.6 M
Dec 2025$11.6 M
Mar 2026$14.0 M
Jun 2026$15.6 M

Free cash

  • Free cash $103 M
Free cash
QuarterFree cash
Sep 2023$29.4 M
Dec 2023−$79.4 M
Mar 2024$118 M
Jun 2024$88.6 M
Sep 2024$47.8 M
Dec 2024−$132 M
Mar 2025$28.0 M
Jun 2025$99.3 M
Sep 2025$46.5 M
Dec 2025−$138 M
Mar 2026$40.3 M
Jun 2026$103 M
Top: capital spending each quarter, $ M. Below: free cash flow, $ M. Last 12 quarters.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

What is Edgewell Personal Care's P/E ratio, and how does it compare with its own history?

Edgewell Personal Care Company has no P/E right now, because its earnings are negative. The revenue and margin sections are where a turn would show first. Measured against sales instead, the market values Edgewell Personal Care Company at 0.6× its FY25 revenue of $2.2 B. The P/E comes back here once profit turns positive.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

PEG 1.21 at the Jun 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate

  • PEG 1.21×
  • PEG = 1.0 1.00×
PEG 1.21 at the Jun 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate
QuarterPEGPEG = 1.0
Sep 20212.46×1.00×
Dec 20212.46×1.00×
Mar 20223.15×1.00×
Jun 20226.00×1.00×
Sep 20226.00×1.00×
Dec 20226.00×1.00×
Mar 20234.33×1.00×
Jun 20233.97×1.00×
Sep 20233.84×1.00×
Dec 20233.35×1.00×
Mar 20242.70×1.00×
Jun 20242.16×1.00×
Sep 20241.41×1.00×
Dec 20241.31×1.00×
Mar 20251.21×1.00×
Jun 20251.21×1.00×
Sep 20251.21×1.00×
Dec 20251.21×1.00×
Mar 20261.21×1.00×
Jun 20261.21×1.00×
PEG each quarter: the P/E divided by the yearly growth rate of earnings. The flat line marks 1.0. Below it the P/E is smaller than the growth rate; above it the P/E is bigger. Last 20 quarters; values above 6 are drawn at the top edge.
—P/E · earnings negative
n/mPEG · cannot be worked out, because 3-year earnings growth is not available

Why the multiple is where it is: over the past year earnings per share moved −73.1% while the price moved +58.4%. The price did better than earnings, which pushed the multiple up within its own range.

Is the Edgewell Personal Care business getting better or worse?

Edgewell Personal Care Company's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 5 quarters of 1 measure, with some gaps.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue −1.3% in FY25, profit −74.2%

  • Revenue growth −1.3%
Growth year by year: revenue −1.3% in FY25, profit −74.2%
QuarterRevenue growth
FY21–
FY224%
FY233.7%
FY240.1%
FY25−1.3%

Profit growth, EPS growth

  • Profit growth −74.2%
  • EPS growth −73.1%
Profit growth, EPS growth
QuarterProfit growthEPS growth
FY21––
FY22−15.5%−13.1%
FY2315.3%19.5%
FY24−14%−10.9%
FY25−74.2%−73.1%
Growth on the year before, each year, %. Top: revenue. Below: net profit and earnings per share, on their own scale because profit growth swings much more. Zero line drawn.

Three growth lines over twelve quarters

  • Revenue 0.1%
Three growth lines over twelve quarters
QuarterRevenue
Sep 20233.7%
Dec 20234.3%
Mar 20242%
Jun 20240.7%
Sep 20240.1%
Dec 2024–
Mar 2025–
Jun 2025–
Sep 2025–
Dec 2025–
Mar 2026–
Jun 2026–

Profit, EPS

  • Profit −14%
  • EPS −11.3%
Profit, EPS
QuarterProfitEPS
Sep 202315.3%19.5%
Dec 20236.4%9%
Mar 202427.7%31.7%
Jun 20240.3%4%
Sep 2024−14%−11.3%
Dec 2024––
Mar 2025––
Jun 2025––
Sep 2025––
Dec 2025––
Mar 2026––
Jun 2026––
Growth on a year earlier, % at each quarter end. Top: revenue. Below: profit and earnings per share, on their own scale because they swing much more. Each is measured over the last 12 months. A gap means there is no reading for that quarter.

ROCE: the return line, worked out each quarter

  • ROCE 8%
ROCE: the return line, worked out each quarter
QuarterROCE
Sep 20237.6%
Dec 20237.2%
Mar 20247.9%
Jun 20248.3%
Sep 20248%
Dec 2024–
Mar 2025–
Jun 2025–
Sep 2025–
Dec 2025–
Mar 2026–
Jun 2026–
Operating profit over the last 12 months (before interest and tax) as a share of average capital employed (total assets minus current liabilities), %.
Stuck lowROCE · latest 8.0%, range 7.2% to 8.3%

Why it matters: with too little history, we say so rather than guess a direction.

There are fewer than eight usable quarters, so this page does not guess a direction from so little history.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue−1.3%+0.8%——
Profit−74.2%−36.6%——
EPS−73.1%−34.1%——
Stock price+58.4%———

How much does Edgewell Personal Care earn on its capital?

Edgewell Personal Care Company earned a ROE of 2% in FY25. Its return on capital used (ROIC) is 2.1 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 1.1% net margin and 0.59× asset turnover (sales divided by assets).

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

Why the return is what it is (FY25): a 1.1% net margin × 0.59× asset turnover × 2.42× leverage (assets divided by equity) ≈ 1.6% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 7.3% − 5.2% = +2.1 percentage points. The 5.2% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error.

FY25: ROE 2%, the full history

  • ROE 1.6%
  • ROIC (annual) 7.4%
  • Cost of capital 5.2%
FY25: ROE 2%, the full history
QuarterROEROIC (annual)Cost of capital
FY217.4%9.4%5.2%
FY226.8%7.2%5.2%
FY237.4%6.8%5.2%
FY246.2%7.5%5.2%
FY251.6%7.4%5.2%
Return on equity each year, % (line); ROIC each year, % (line). 5-year window, low years included. The flat line is the 5.2% cost of capital used on this page.

Jun 2026: ROIC 4.3% (last 12 months) against a 5.2% cost of capital

  • ROIC (12 months) 4.3%
  • ROE (12 months) 1.1%
  • Cost of capital 5.2%
Jun 2026: ROIC 4.3% (last 12 months) against a 5.2% cost of capital
QuarterROIC (12 months)ROE (12 months)Cost of capital
Sep 20236.9%13.9%5.2%
Dec 20236.7%7.7%5.2%
Mar 20246.7%1.2%5.2%
Jun 20247.3%9.3%5.2%
Sep 20247.7%12.5%5.2%
Dec 20247.7%2.2%5.2%
Mar 20257.2%−2.6%5.2%
Jun 20256.4%5.5%5.2%
Sep 20255.5%5.6%5.2%
Dec 20255%−7.8%5.2%
Mar 20264.8%−7.7%5.2%
Jun 20264.3%1.1%5.2%
ROIC and ROE over the last 12 months, each quarter, %; the flat line is the cost of capital. Last 12 quarters, lined up with the yearly figure.

Does Edgewell Personal Care have too much debt?

Edgewell Personal Care Company has total debt of $1.3 B against shareholder equity of $1.5 B as of Jun 2026, so its debt is 0.88× its equity. Year by year, that ratio went from 0.83 in FY21 to 0.96 in FY25. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

FY25: debt $1.5 B, 0.96× equity

  • Total debt $1.5 B
FY25: debt $1.5 B, 0.96× equity
QuarterTotal debt
FY21$1.3 B
FY22$1.5 B
FY23$1.4 B
FY24$1.4 B
FY25$1.5 B

Debt-to-equity

  • Debt-to-equity 0.96×
Debt-to-equity
QuarterDebt-to-equity
FY210.83×
FY221.00×
FY230.94×
FY240.87×
FY250.96×
Top: total debt each year, $ B. Below: debt-to-equity, ×. 5-year window.

Jun 2026: debt $1.3 B, debt-to-equity 0.88

  • Total debt (quarterly) $1.3 B
Jun 2026: debt $1.3 B, debt-to-equity 0.88
QuarterTotal debt (quarterly)
Sep 2023$1.4 B
Dec 2023$1.5 B
Mar 2024$1.4 B
Jun 2024$1.3 B
Sep 2024$1.4 B
Dec 2024$1.5 B
Mar 2025$1.5 B
Jun 2025$1.4 B
Sep 2025$1.5 B
Dec 2025$1.6 B
Mar 2026$1.3 B
Jun 2026$1.3 B

Debt-to-equity

  • Debt-to-equity 0.88×
Debt-to-equity
QuarterDebt-to-equity
Sep 20230.94×
Dec 20230.96×
Mar 20240.89×
Jun 20240.83×
Sep 20240.87×
Dec 20240.98×
Mar 20250.98×
Jun 20250.90×
Sep 20250.96×
Dec 20251.05×
Mar 20260.88×
Jun 20260.88×
Top: total debt each quarter, $ B. Below: debt-to-equity, ×. Last 12 quarters.

What is the Edgewell Personal Care shareholding pattern?

11.2% of Edgewell Personal Care Company's tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 8.0 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

It is a single reading at one point in time; we do not have its history.

11.2%Short interest · of the tradable float
8.0Days to cover · at typical volumes

Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.

How far is Edgewell Personal Care from balance-sheet trouble?

For Edgewell Personal Care Company, the Z-score is 1.65. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why it matters: a Z-score of 1.65 is inside the danger zone, so the balance sheet is a real risk.

How does Edgewell Personal Care rank in its industry?

42.1 out of 100, rank 14 of 20 in Household & Personal Products, with 71% of the evidence available.

Edgewell Personal Care Company scores 42.1 out of 100 against the 20 companies it is compared with in Household & Personal Products, ranking 14. Relative strength against the index is 21.8%, and revenue and profit growth are weak.

The four parts add up to the total exactly: 10.7 + 7.1 + 11.2 + 13.1 = 42.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is Edgewell Personal Care compared with?

Edgewell Personal Care ranks 14 of 20 Household & Personal Products companies on the 4-Factor Sector Score, with 42.1 out of 100.

  1. 1Kenvue Inc.KVUE · Evidence leans up · 61% evidence63.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 27.7/43.75 · Revenue 1.8% · Profit 16.9% · Operating margin change -0.4 points · 83% evidenceCapital efficiency 21.1/31.25 · ROCE 14.4% · Operating margin 19.4% · 76% evidenceValuation 15.1/25 · P/E 22.2× · PEG 1.37 · 65% evidenceRelative strength: no reading this week · its 20 points are shared across the other threeExact sum: 27.7 + 21.1 + 15.1 = 63.9 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone.
  2. 2The Estée Lauder Companies Inc.EL · leader · Evidence leans up · 64% evidence59.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 23.7/35 · Revenue 5% · Profit — · Operating margin change 2.7 points · 62% evidenceCapital efficiency 11.0/25 · ROCE 12.3% · Operating margin 7% · 76% evidenceValuation 11.5/20 · P/E -104.7× · PEG — · 15% evidenceRelative strength 13.7/20 · Lead over its industry 0.3% · Lead over S&P 500 11.6% · 1 year 27.8% · 100% evidence · 12 of 12 weeks aheadExact sum: 23.7 + 11 + 11.5 + 13.7 = 59.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  3. 3Church & Dwight Co., Inc.CHD · turning · Evidence leans up · 81% evidence58.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 18.6/35 · Revenue 2.7% · Profit 41.9% · Operating margin change -2.7 points · 83% evidenceCapital efficiency 15.8/25 · ROCE 14.6% · Operating margin 18.1% · 76% evidenceValuation 14.3/20 · P/E 30.8× · PEG 0.66 · 65% evidenceRelative strength 10.0/20 · Lead over its industry -1.8% · Lead over S&P 500 9.7% · 1 year 29% · 100% evidence · 2 of 12 weeks aheadExact sum: 18.6 + 15.8 + 14.3 + 10 = 58.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  4. 4The Procter & Gamble CompanyPG · turning · Evidence leans up · 85% evidence57.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.7/35 · Revenue 3.5% · Profit -4.4% · Operating margin change 0.3 points · 95% evidenceCapital efficiency 21.2/25 · ROCE 24.6% · Operating margin 27.1% · 76% evidenceValuation 6.7/20 · P/E 21.4× · PEG 2.4 · 65% evidenceRelative strength 10.0/20 · Lead over its industry -5.7% · Lead over S&P 500 5.3% · 1 year 13.9% · 100% evidence · 3 of 12 weeks aheadExact sum: 19.7 + 21.2 + 6.7 + 10 = 57.6 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value.
  5. 5Colgate-Palmolive CompanyCL · turning · Evidence leans up · 81% evidence55.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.2/35 · Revenue 5.2% · Profit -29.2% · Operating margin change 0.1 points · 83% evidenceCapital efficiency 21.1/25 · ROCE 40.8% · Operating margin 21% · 76% evidenceValuation 7.7/20 · P/E 36× · PEG 2.18 · 65% evidenceRelative strength 7.0/20 · Lead over its industry -6.1% · Lead over S&P 500 4.9% · 1 year 25.3% · 100% evidence · 1 of 12 weeks aheadExact sum: 19.2 + 21.1 + 7.7 + 7 = 55 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6Helen of Troy LimitedHELE · turning · Evidence leans up · 67% evidence54.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 14.8/35 · Revenue 0.3% · Profit — · Operating margin change -2.6 points · 71% evidenceCapital efficiency 9.4/25 · ROCE 9.8% · Operating margin 0.5% · 76% evidenceValuation 10.7/20 · P/E -7.1× · PEG — · 15% evidenceRelative strength 19.1/20 · Lead over its industry 34.2% · Lead over S&P 500 49.9% · 1 year 90.9% · 100% evidence · 3 of 12 weeks aheadExact sum: 14.8 + 9.4 + 10.7 + 19.1 = 54 · What this means: Relative strength against the index is 49.9%, and revenue and profit growth are weak.
  7. 7Acme United CorporationACU · leader · Evidence leans up · 81% evidence52.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 16.8/35 · Revenue 9.3% · Profit -9.1% · Operating margin change -0.9 points · 83% evidenceCapital efficiency 10.9/25 · ROCE 8.7% · Operating margin 10.9% · 76% evidenceValuation 6.7/20 · P/E 18.5× · PEG 2.5 · 65% evidenceRelative strength 18.4/20 · Lead over its industry 23.1% · Lead over S&P 500 37% · 1 year 92% · 100% evidence · 12 of 12 weeks aheadExact sum: 16.8 + 10.9 + 6.7 + 18.4 = 52.8 · What this means: Relative strength against the index is 37%, and revenue and profit growth are weak.
  8. 8Interparfums, Inc.IPAR · turning · Evidence leans up · 81% evidence52.3out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 13.9/35 · Revenue 2.9% · Profit 4.4% · Operating margin change -5.4 points · 83% evidenceCapital efficiency 17.9/25 · ROCE 21% · Operating margin 12.3% · 76% evidenceValuation 9.7/20 · P/E 21.4× · PEG 1.99 · 65% evidenceRelative strength 10.8/20 · Lead over its industry 2.6% · Lead over S&P 500 14.4% · 1 year 41.4% · 100% evidence · 5 of 12 weeks aheadExact sum: 13.9 + 17.9 + 9.7 + 10.8 = 52.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  9. 9Kimberly-Clark CorporationKMB · turning · Evidence leans up · 81% evidence50.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.1/35 · Revenue 0.7% · Profit -18.9% · Operating margin change 2.8 points · 83% evidenceCapital efficiency 20.6/25 · ROCE 24.6% · Operating margin 19% · 76% evidenceValuation 7.6/20 · P/E 18.6× · PEG 2.38 · 65% evidenceRelative strength 5.5/20 · Lead over its industry -11.5% · Lead over S&P 500 -1.2% · 1 year 4.9% · 100% evidence · 2 of 12 weeks aheadExact sum: 17.1 + 20.6 + 7.6 + 5.5 = 50.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  10. 10Newell Brands Inc.NWL · losing its lead · Evidence leans up · 64% evidence50.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.3/35 · Revenue -2% · Profit — · Operating margin change 5.2 points · 62% evidenceCapital efficiency 8.6/25 · ROCE 7.3% · Operating margin 14.7% · 76% evidenceValuation 11.0/20 · P/E -11.8× · PEG — · 15% evidenceRelative strength 11.9/20 · Lead over its industry 6.7% · Lead over S&P 500 18.7% · 1 year 84.9% · 100% evidence · 7 of 12 weeks aheadExact sum: 19.3 + 8.6 + 11 + 11.9 = 50.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  11. 11e.l.f. Beauty, Inc.ELF · leader · Evidence leans down · 81% evidence48.2out of 100GrowthCapitalValuationRelative
  12. 12Spectrum Brands Holdings, Inc.SPB · turning · Evidence leans down · 81% evidence46.3out of 100GrowthCapitalValuationRelative
  13. 13Coty Inc.COTY · breaking out · Evidence leans down · 64% evidence43.8out of 100GrowthCapitalValuationRelative
  14. 14Edgewell Personal Care Company this pageEPC · turning · Evidence leans down · 71% evidence42.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 10.7/35 · Revenue 2% · Profit -244.6% · Operating margin change -2.3 points · 83% evidenceCapital efficiency 7.1/25 · ROCE 4.9% · Operating margin 8.8% · 76% evidenceValuation 11.2/20 · P/E -13.3× · PEG — · 15% evidenceRelative strength 13.1/20 · Lead over its industry 9.4% · Lead over S&P 500 21.8% · 1 year 58.4% · 100% evidence · 6 of 12 weeks aheadExact sum: 10.7 + 7.1 + 11.2 + 13.1 = 42.1 · What this means: Relative strength against the index is 21.8%, and revenue and profit growth are weak.
  15. 15Magnera CorporationMAGN · quiet · Evidence leans down · 64% evidence39.7out of 100GrowthCapitalValuationRelative
  16. 16The Clorox CompanyCLX · basing · Evidence leans down · 81% evidence38.1out of 100GrowthCapitalValuationRelative
  17. 17The Honest Company, Inc.HNST · losing its lead · Most evidence points down · 71% evidence34.4out of 100GrowthCapitalValuationRelative
  18. 18Nu Skin Enterprises, Inc.NUS · basing · Most evidence points down · 71% evidence30.6out of 100GrowthCapitalValuationRelative
  19. 19Oddity Tech Ltd.ODD · breaking out · Most evidence points down · 81% evidence24.7out of 100GrowthCapitalValuationRelative
  20. 20Unilever PLCUL · turning · Too little evidence to rank firmly · 47% evidence49.6out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Household & Personal Products, all 20 compared on one page.

Which companies are close to Edgewell Personal Care in size?

Edgewell Personal Care is the 14th largest of 22 Household & Personal Products companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Coty Inc., Newell Brands Inc. and Spectrum Brands Holdings, Inc. Just below it: Oddity Tech, Helen of Troy and The Honest Company, Inc.

Household & Personal Products companies close in size

  1. Coty Inc. $3.1 billion
  2. Newell Brands Inc. $2.5 billion
  3. Spectrum Brands Holdings, Inc. $2.1 billion
  4. Edgewell Personal Care Company $1.4 billion
  5. Oddity Tech Ltd. $995 million
  6. Helen of Troy Limited $866 million
  7. The Honest Company, Inc. $476 million

All 22 Household & Personal Products companies, largest first

Companies close in size in other industries

  1. Securitize Corp. $1.4 billion · Financial Data & Stock Exchanges
  2. HBT Financial, Inc. $1.4 billion · Banks - Regional
  3. Edgewell Personal Care Company $1.4 billion
  4. The Greenbrier Companies, Inc. $1.4 billion · Railroads
  5. Dorchester Minerals, L.P. $1.4 billion · Oil & Gas Exploration & Production

What else do people ask about Edgewell Personal Care?

What were Edgewell Personal Care's latest quarterly results?

Edgewell Personal Care Company reported revenue of $570 M and net profit of $13.7 M for the Jun 2026 quarter. Earnings per share were $0.29. The operating margin was 8.8% (as of 4 November 2026).

What is Edgewell Personal Care's market cap?

Edgewell Personal Care Company's market capitalisation is $1.4 B at a stock price of $29.66. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is Edgewell Personal Care performing?

Edgewell Personal Care Company's latest readings are below. Over the past 13 weeks it has done better than the S&P 500, for 2 weeks running. This describes what the data did, not a rating (as of 4 November 2026).

Will Edgewell Personal Care's stock price go up?

This page does not forecast Edgewell Personal Care Company's stock price. What it shows instead: the stock price is $29.66. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026).

Where is Edgewell Personal Care in its business cycle?

Edgewell Personal Care Company's FY25 operating margin was 9.3%, against a 5-year range of 9.3% to 13.5%: the low end of its own range, which is often where recoveries start. The latest quarter was 8.8%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the Edgewell Personal Care story?

The main question: the share price moved +58.4% in a year while yearly earnings per share moved −73.1%. The difference came from the market paying a higher multiple.

On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is Edgewell Personal Care a stock worth studying right now?

What the numbers show: Edgewell Personal Care Company's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.